4.6 Article

Advances in prebiotic mannooligosaccharides

Journal

CURRENT OPINION IN FOOD SCIENCE
Volume 47, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cofs.2022.100883

Keywords

-

Funding

  1. Indian Council of Medical Research (ICMR) , New Delhi [2021-14350]
  2. RC (SRF)
  3. UKJ (Senior Research Fellowship) [2019-4132]

Ask authors/readers for more resources

This article presents the latest developments related to the production and applications of prebiotic mannooligosaccharides (MOS), highlighting the health benefits they provide, including antineoplastic, immunomodulatory, and hypolipidemic effects. The article also explores the potential usage of MOS as functional food ingredients for humans.
Prebiotic mannooligosaccharides (MOS) are small chains of mannose that are known to confer health benefits to the consumers. At present, commercial MOS are derived by the degradation of yeast cell-wall mannans. MOS are also synthesized by the physicochemical or enzymatic treatment of naturally occurring mannans. Recently, these oligomers are being explored for their role in the modulation of beneficial gut microbiota of animals and their possible usage as functional food ingredients in humans. Experimental evidences strongly point out that dietary MOS impart numerous health benefits, including antineoplastic, immunomodulatory, and hypolipidemic effects, indicating that they have immense potential as a functional food ingredient. In this article, we present up-to-date developments related to the production and applications of MOS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available